injectable aids drug may work
Last Updated : GMT 09:40:38
Themuslimchronicle, themuslimchronicle
Themuslimchronicle, themuslimchronicle
Last Updated : GMT 09:40:38
Themuslimchronicle, themuslimchronicle

'As Well' as Pills

Injectable AIDS Drug May Work

Themuslimchronicle, themuslimchronicle

Themuslimchronicle, themuslimchronicleInjectable AIDS Drug May Work

A two-drug cocktail injected
New York - Muslimchronicle

A two-drug cocktail injected every month or two may be just as effective as a daily pill at keeping the AIDS virus under control, said a study Monday that promised relief for millions.

At present people have no option but to take lifelong, daily doses of anti-retroviral therapy (ART) which keeps the HIV virus under control, but does not kill it.

People who forget to take their medication run the risk of the virus rebounding to make them ill, or developing resistance to the drugs they were using -- which would require a more expensive replacement.

In an ongoing study, nearly 300 HIV-positive people were given an initial course of daily pills to bring the virus under control. 

Once this was achieved, some continued taking oral treatment as maintenance while the rest were shifted onto the prototype, injectable ARV, administered every four or eight weeks.

At 96 weeks, the virus was still subdued in 84 percent of the pill-taking group, 87 percent in the four-weekly injectable group, and 94 percent in the eight-weekly group.

The results were published in The Lancet medical journal to coincide with an HIV science conference in Paris of the International AIDS Society.

In 2016, there were some 36.7 million people living with HIV of whom 19.5 million had access to ART, according to UNAIS.

The UN recommends ART for all HIV-positive people.

- 'Next revolution' -"The introduction of single-tablet medication represented a leap forward in ART dosing, and long-active anti-retroviral injections may represent the next revolution in HIV therapy by providing an option that circumvents the burden of daily dosing," said study oc-author David Margo lis of Vi Iv Healthcare, a pharmaceutical company involved in developing the injectable drug.

"Adherence to medication remains an important challenge in HIV treatment."

Also involved in the study is Janssen Sciences, a company in the Johnson & Johnson group.

Last week, the UN warned that countries must halt the rise of AIDS drug resistance to prevent a swell in new infections and deaths and spiralling treatment costs.

Viruses can become resistant to drugs when people take incorrect doses of their prescribed medication. Resistant strains can also be contracted directly from other people.

Some in the trial group experienced mild or moderate pain at the injection site, two of whom two to stop getting the shots which contain a mix of cabotegravir and rilpivirine.

Other side-effects, including diarrhoea and headaches, were similar in all the groups.

"Trials are ongoing and are needed to confirm the results," the researchers said a statement.

The experiments were conducted in the United States, Germany, Canada, Spain, France and Germany.

Source: AFP

themuslimchronicle
themuslimchronicle

GMT 07:55 2017 Tuesday ,26 December

Florida orange industry hit

GMT 08:18 2017 Monday ,18 December

Judge Temporarily Blocks New rules

GMT 00:27 2017 Saturday ,02 December

Serious health risks waste burning

GMT 12:13 2017 Tuesday ,17 October

Mass Cholera Vaccinations Begin

GMT 07:54 2017 Saturday ,19 August

UN demands civilian access
Themuslimchronicle, themuslimchronicle
Themuslimchronicle, themuslimchronicle

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

injectable aids drug may work injectable aids drug may work

 



Themuslimchronicle, themuslimchronicle

GMT 12:04 2017 Wednesday ,27 September

Thomas Cook sees tourists return to Turkey and Egypt

GMT 20:15 2017 Friday ,17 March

Attack On Aid Convoy in South Sudan Kills Two

GMT 17:32 2017 Friday ,15 September

At least 33 dead in Nigeria boat capsize

GMT 17:23 2013 Friday ,24 May

Woolwich: Terrorism or political murder?

GMT 17:52 2017 Tuesday ,18 April

Meningitis kills 10 more people in NW Nigeria

GMT 18:08 2017 Tuesday ,17 October

Norway solar firm signs 2.5 bn-euro deal with Iran

GMT 07:43 2018 Monday ,22 January

Macron boosts Merkel ahead of key coalition vote

GMT 05:32 2016 Monday ,18 April

Australian dollar falls amid oil talk breakdown

GMT 04:45 2016 Thursday ,15 December

UAE Ambassador and Chilean Energy Minister discuss

GMT 15:34 2011 Saturday ,19 November

Williams to resume sibling rivalry in exhibition

GMT 13:03 2017 Tuesday ,14 March

Snoop Dogg shoots at Trump in new video

GMT 09:37 2016 Monday ,19 September

Southeast Asian haze crisis killed over 100,000

GMT 08:27 2015 Monday ,19 October

Patriots down Colts in 'Deflategate' rematch

GMT 16:36 2017 Tuesday ,12 September

Quarter of houses in Florida Keys destroyed

GMT 21:22 2016 Thursday ,23 June

Poll: Israelis even on Clinton vs. Trump
Themuslimchronicle, themuslimchronicle
Themuslimchronicle, themuslimchronicle
 
 Themuslimchronicle Facebook,themuslimchronicle facebook  Themuslimchronicle Twitter,themuslimchronicle twitter Themuslimchronicle Rss,themuslimchronicle rss  Themuslimchronicle Youtube,themuslimchronicle youtube  Themuslimchronicle Youtube,themuslimchronicle youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©

muslimchronicle muslimchronicle muslimchronicle muslimchronicle
themuslimchronicle themuslimchronicle themuslimchronicle
themuslimchronicle
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
themuslimchronicle, themuslimchronicle, themuslimchronicle